Viking Therapeutics, Inc.
VKTX
$23.94
$0.341.44%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 149.29% | 147.30% | 139.81% | 609.82% | 132.87% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -55.27% | 158.66% | -85.63% | -83.62% | -26.06% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 32.47% | 1.98% | -39.48% | -72.50% | -67.78% |
| Total Current Assets | 147.05% | 145.65% | 136.80% | 546.52% | 119.84% |
|
|
|||||
| Total Current Assets | 147.05% | 145.65% | 136.80% | 546.52% | 119.84% |
| Net Property, Plant & Equipment | -10.92% | -7.25% | -23.25% | -21.84% | -20.59% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -26.62% | -22.70% | 181.63% | 61.73% | 95.77% |
| Total Assets | 146.50% | 145.10% | 136.30% | 541.19% | 118.65% |
|
|
|||||
| Total Accounts Payable | 30.63% | -95.55% | 97.65% | 37.54% | -11.92% |
| Total Accrued Expenses | 51.44% | 238.32% | 80.97% | 135.85% | -13.84% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 50.93% | 50.47% | 6.37% | 6.47% | 6.58% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 43.26% | 91.61% | 86.18% | 109.43% | -12.81% |
|
|
|||||
| Total Current Liabilities | 43.26% | 91.61% | 86.18% | 109.43% | -12.81% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -32.69% | -25.83% | -30.36% | -27.86% | -25.71% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 39.72% | 83.32% | 77.38% | 99.80% | -13.51% |
|
|
|||||
| Common Stock & APIC | 86.62% | 86.80% | 86.38% | 195.94% | 64.74% |
| Retained Earnings | -29.10% | -28.06% | -29.25% | -30.08% | -29.41% |
| Treasury Stock & Other | 89.03% | 121.19% | 71.00% | 78.43% | 9.03% |
| Total Common Equity | 152.65% | 147.51% | 138.52% | 596.60% | 139.76% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 152.65% | 147.51% | 138.52% | 596.60% | 139.76% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 152.65% | 147.51% | 138.52% | 596.60% | 139.76% |
|
|
|||||